Key result
Administration of 3-AB significantly reduced oxidative stress markers, inhibited PARP activation, and prevented energy depletion in a rat model of heart transplantation reperfusion injury.
Why the study?
Does 3-aminobenzamide reduce ischemia/reperfusion injury in a rat heart transplantation model?
Does 3-aminobenzamide reduce ischemia/reperfusion injury in a rat heart transplantation model?
PARP inhibition with 3-aminobenzamide attenuates myocardial ischemia/reperfusion injury in a rat heart transplant model by preventing energy depletion.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for PARP inhibition in transplant reperfusion injury; requires human validation before clinical consideration.
Fiorillo et al. (2003) studied Ischemia/reperfusion injury in heart transplantation. 3-aminobenzamide (3-AB) vs. Untreated IR heart and inactive analogue 3-aminobenzoic acid was evaluated on Oxidative stress markers, PARP activation, NAD+ and ATP levels, and morphological cardiomyocyte alterations. Administration of 3-AB significantly reduced oxidative stress markers, inhibited PARP activation, and prevented energy depletion in a rat model of heart transplantation reperfusion injury.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: